Hempacco Co., Inc. (HPCO) Cash Flow Statement
Where HPCO’s cash came from and went, 2024
December 31, 2024 · U.S. dollars- Cash from operations
- −$5.8M
- Capital expenditures
- $410,301 10.1% of revenue
- Free cash flow
- −$6.3M −154.6% margin
- Returned to shareholders
- —
- Change in cash
- −$438,506 cash at year-end $109,825
Drawn to scale: where the cash came from and how it was used. Hover for values.
HPCO operating cash flow, capex and free cash flow
HPCO cash flow trends, 2019–2024
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Operating cash flow | −$66,5832019 | −$5.8M2024 | — | |
| Capital expenditures | $51,4312019 | $410,3012024 | +51.5%/yr | |
| Free cash flow | −$66,5832019 | −$6.3M2024 | — | |
| Free cash flow margin | −35.0%2020 | −154.6%2024 | −119.6 pts | |
| Stock-based compensation | $02020 | $448,9562024 | — | |
| Capex / revenue | 14.9%2020 | 10.1%2024 | −4.7 pts |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
HPCO cash flow by activity
HPCO net income vs operating cash flow
Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).
HPCO cash flow statement
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Operating activities | ||||||
| Net income | −$13.4M | −$13.1M | −$7.1M | −$1.9M | −$1.5M | −$53,345 |
| Depreciation & amortization | $398,989 | $398,989 | $96,922 | $86,501 | $69,519 | $5,333 |
| Stock-based compensation | $448,956 | $448,956 | $248,103 | $100,000 | $0 | — |
| Change in working capital | $2.1M | $2.1M | −$1.3M | $594,600 | $1.2M | −$18,571 |
| Other non-cash items | $4.6M | $4.3M | $3.7M | $358,613 | $154,162 | $0 |
| Cash from operating activities | −$5.8M | −$5.8M | −$4.4M | −$730,961 | −$69,686 | −$66,583 |
| Investing activities | ||||||
| Capital expenditures | −$410,301 | −$410,301 | −$103,868 | −$79,963 | −$51,431 | −$51,431 |
| Investments (net) | — | −$3.6M | −$63,868 | −$79,963 | −$51,431 | — |
| Acquisitions & other investing | −$3.2M | — | $103,868 | $79,963 | $51,431 | $0 |
| Cash from investing activities | −$3.6M | — | −$63,868 | −$79,963 | −$51,431 | −$51,431 |
| Financing activities | ||||||
| Net borrowing (repayment) | — | $2.6M | −$250,900 | $716,328 | $121,500 | $88,933 |
| Shares issued | $0 | $7.2M | $6.4M | $1.3M | $0 | $0 |
| Other financing | $9.0M | −$784,600 | −$2.1M | −$272,435 | $0 | −$22,233 |
| Cash from financing activities | $9.0M | $9.0M | $4.0M | $1.7M | $121,500 | $66,700 |
| Summary | ||||||
| Net change in cash | −$438,506 | −$438,506 | −$385,138 | $932,969 | $383 | $117 |
| Cash at end of period | $109,825 | $109,825 | $548,331 | $933,469 | $500 | $117 |
| Free cash flow | −$6.3M | −$6.3M | −$4.5M | −$810,924 | −$121,117 | −$66,583 |
| Free cash flow margin | −154.6% | −154.6% | −112.8% | −68.3% | −35.0% | — |
| Capex / revenue | 10.1% | 10.1% | 2.6% | 6.7% | 14.9% | — |
| Jun '24 | Dec '23 | Sep '23 | Jun '23 | Mar '23 | Dec '22 | Sep '22 | Jun '22 | Mar '22 | Dec '21 | Sep '21 | Jun '21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||||
| Net income | −$7.0M | −$6.9M | −$2.3M | −$1.6M | −$5.1M | −$5.0M | −$1.0M | −$97,350 | −$877,216 | −$673,972 | −$367,303 | −$494,961 |
| Depreciation & amortization | $282,182 | $282,182 | $52,959 | $33,196 | −$74,176 | $30,652 | $125,881 | $22,813 | $22,404 | $13,469 | $37,035 | $11,753 |
| Stock-based compensation | $128,556 | — | $307,500 | $12,900 | $148,103 | — | $100,000 | — | — | $0 | — | — |
| Change in working capital | $2.9M | $2.9M | $534,170 | −$501,585 | $661,360 | $661,360 | −$1.3M | $86,531 | −$727,717 | $717,468 | $52,027 | −$116,923 |
| Other non-cash items | $2.8M | $2.9M | $216,363 | $201,598 | $3.2M | $2.3M | $0 | $0 | $448,065 | $178,317 | $0 | $250,615 |
| Cash from operating activities | −$872,582 | −$872,582 | −$1.2M | −$1.9M | −$1.2M | −$2.0M | −$2.1M | $11,994 | −$1.1M | $235,282 | −$278,241 | −$349,516 |
| Investing activities | ||||||||||||
| Capital expenditures | −$247,117 | −$247,117 | −$14,998 | −$112,000 | −$65,530 | −$36,187 | −$162,387 | −$2,999 | −$4,012 | −$62,674 | −$17,289 | −$3,750 |
| Investments (net) | — | −$3.4M | −$14,998 | −$111,999 | −$36,187 | $218,139 | −$314,996 | −$2,999 | $35,988 | −$62,674 | −$20,025 | $6,486 |
| Acquisitions & other investing | −$3.2M | — | $14,998 | $111,999 | $319,856 | −$218,139 | $162,387 | $2,999 | $4,012 | $62,674 | $17,289 | $3,750 |
| Cash from investing activities | −$3.4M | — | −$14,998 | −$112,000 | $218,139 | −$36,187 | −$314,996 | −$2,999 | $35,988 | −$62,674 | −$20,025 | $6,486 |
| Financing activities | ||||||||||||
| Dividends paid | — | — | — | −$85,312 | −$52,000 | — | — | — | — | — | — | — |
| Share repurchases & issuance (net) | $14,250 | — | — | −$14,250 | −$52,000 | — | — | — | — | — | — | — |
| Net borrowing (repayment) | — | — | — | — | −$1.1M | −$1.1M | −$204,602 | −$303,832 | $188,055 | −$311,558 | — | — |
| Shares issued | $0 | $0 | $14,250 | $14,250 | $7.2M | $0 | $6.1M | $0 | $0 | $1.3M | $0 | $0 |
| Other financing | $4.4M | $4.4M | −$217,771 | −$587,895 | −$7.5M | $6.6M | −$531,188 | $355,475 | −$16,000 | −$272,435 | $342,606 | $151,951 |
| Cash from financing activities | $4.4M | $4.4M | −$203,521 | −$673,207 | −$1.5M | $5.5M | $5.3M | $51,643 | $172,055 | $716,007 | $342,606 | $151,951 |
| Summary | ||||||||||||
| Net change in cash | $92,749 | $92,749 | −$1.4M | −$2.7M | −$2.4M | $3.5M | $2.9M | $60,638 | −$926,421 | $888,615 | $44,340 | −$191,079 |
| Cash at end of period | $109,825 | $109,825 | $17,076 | $1.4M | $548,331 | $548,331 | $3.0M | $67,686 | $7,048 | $933,469 | $44,854 | $514 |
| Free cash flow | −$1.1M | −$1.1M | −$1.2M | −$2.0M | −$1.1M | −$1.1M | −$2.3M | $8,995 | −$1.1M | $172,608 | −$295,530 | −$345,766 |
| Free cash flow margin | −54.9% | −54.9% | −87.9% | −776.6% | −205.6% | −205.6% | −381.2% | 0.5% | −117.2% | 62.5% | −69.5% | −99.2% |
| Capex / revenue | 12.1% | 12.1% | 1.1% | 44.0% | 12.4% | 6.8% | 27.4% | 0.2% | 0.4% | 22.7% | 4.1% | 1.1% |
Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.
HPCO cash generation
In fiscal 2024 (ended December 31, 2024), Hempacco generated -$5.8 million of cash from operations and spent $0.4 million on capital expenditures, leaving free cash flow of -$6.3 million, −154.6% of revenue. Cash and equivalents fell by $0.4 million over the year.
Related: HPCO income statement, HPCO balance sheet. See the HPCO stock overview for the latest quote and news.
HPCO cash flow FAQ
What is Hempacco's free cash flow?
Hempacco's free cash flow was -$6.3 million in fiscal 2024: -$5.8 million of operating cash flow minus $0.4 million of capital expenditures It was -$6.3 million a year earlier..
How much cash does Hempacco generate from operations?
Hempacco generated -$5.8 million of cash from operating activities in fiscal 2024.
How much does Hempacco spend on capital expenditures?
Hempacco spent $0.4 million on capital expenditures in fiscal 2024, 10.1% of revenue, compared with $0.4 million the year before.